Involved node radiation therapy in the combined modality treatment for early-stage Hodgkin lymphoma: Analysis of relapse location and long-term outcome.
CONCLUSIONS: Modern treatment with brief chemotherapy and limited radiotherapy provides excellent long-term disease control in ESHL. Neither bulk, high FDG-uptake, nor residual CT abnormality after chemotherapy could predict initially involved lymph nodes with a high risk of relapse.
PMID: 32622782 [PubMed - as supplied by publisher]
Source: Radiotherapy and Oncology : journal of the European Society for Therapeutic Radiology and Oncology - Category: Radiology Authors: Nielsen K, Vestmoe Maraldo M, Kiil Berthelsen A, Loft A, de Nully Brown P, Richter Vogelius I, Meidahl Petersen P, Specht L Tags: Radiother Oncol Source Type: research
More News: Cancer & Oncology | Chemotherapy | CT Scan | Hodgkin's Disease | Lymphoma | PET Scan | Radiation Therapy | Radiology